94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Endocrinol. , 04 March 2022
Sec. Cancer Endocrinology
Volume 13 - 2022 | https://doi.org/10.3389/fendo.2022.745327
This article is part of the Research Topic Thyroid Hormone Actions in Cancer View all 6 articles
A retraction of this article was approved in:
Retraction: In vivo clearance of apoptotic debris from tumor xenografts exposed to chemically modified tetrac: is there a role for thyroid hormone analogues in efferocytosis?
Citation: Godugu K, Mousa SA, Glinsky GV, Lin H-Y and Davis PJ (2022) In Vivo Clearance of Apoptotic Debris From Tumor Xenografts Exposed to Chemically Modified Tetrac: Is There a Role for Thyroid Hormone Analogues in Efferocytosis? Front. Endocrinol. 13:745327. doi: 10.3389/fendo.2022.745327
Received: 16 September 2021; Accepted: 28 January 2022;
Published: 04 March 2022; Retracted: 21 August 2024.
Edited by:
Maria Del Mar Montesinos, CONICET Centre for Research in Clinical Biochemistry and Immunology (CIBICI), ArgentinaReviewed by:
Maria Celeste Diaz Flaqué, CONICET Institute for Biomedical Research (BIOMED), ArgentinaDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.